Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [8]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Bartkova et al. 2006
In the citing paper
“Colon adenomas, which are stable precursor lesions of invasive colon cancer, were found to be negative for the proliferation marker Ki67 and positive for SA- β- gal 87,88 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“colon adenoma- derived samples also have elevated expression of p16 INK4a , HP1γ (an H3K9me3- enriched senescence- associated heterochromatin focus- promoting scaffold that connects H3K9 methyltransferases to Rb as another binding partner), and focal γH2AX expression, indicating enhanced DNA damage 87,89 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
From Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence (2009) · cites this paper as [3]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Cited by
Items 501–600 of 1,016
Romanov, V. S., Abramova, M. V., Svetlikova, S. B., Bykova, T. V., Zubova, S. G., Aksenov, N. D., Fornace, A. J., Pospelova, T. V., & Pospelov, V. A. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13160 · Cited by 80
“Transformation of normal cells induced by oncogene activation is restrained by triggering the program of cellular senescence.(6,7) The block of cell cycle in case of premature cell senescence has many common features with cell cycle arrest, which is induced by DNA damaging and stress factors and is often based on acti…”
BackgroundCheng, W., Muftic, D., Müftüoğlu, M., Dawut, L., Morris, C., Helleday, T., Shiloh, Y., & Bohr, V. A. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-07-0698 · Cited by 92
Self-citationCellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy
Yin, H., & Pickering, J. G. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.051 · Cited by 82
Orba, Y., Suzuki, T., Makino, Y., Kubota, K., Tanaka, S., Kimura, T., & Sawa, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064311 · Cited by 87
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo
Reimann, M., Loddenkemper, C., Rudolph, C., Schildhauer, I., Teichmann, B., Stein, H., Schlegelberger, B., Dörken, B., & Schmitt, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075614 · Cited by 78
Human Nuclease/Helicase DNA2 Alleviates Replication Stress by Promoting DNA End Resection
Peng, G., Dai, H., Zhang, W., Hsieh, H.-J., Pan, M.-R., Park, Y.-Y., Tsai, R. Y.-L., Bedrosian, I., Lee, J.-S., Ira, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3152 · Cited by 73
Hassel, C. A., Zhang, B., Dixon, M. J., & Calvi, B. R. (2013) · Development · doi:10.1242/dev.098871 · Cited by 84
“If the level of genomic DNA damage is severe, however, the cell can actively withdraw from the cell cycle into an inactive state known as senescence, or engage a programmed cell death (PCD), often through a pathway known as apoptosis (Bartkova et al., 2006; Fuchs and Steller, 2011).”
BackgroundSenescence-associated microRNAs target cell cycle regulatory genes in normal human lung fibroblasts
Markopoulos, G. S., Roupakia, E., Tokamani, M., Vartholomatos, G., Tzavaras, T., Hatziapostolou, M., Fackelmayer, F. O., Sandaltzopoulos, R., Polytarchou, C., & Kolettas, E. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.017 · Cited by 88
Self-citationComplex engagement of DNA damage response pathways in human cancer and in lung tumor progression
Nuciforo, P. G., Luise, C., Capra, M., Pelosi, G., & d'Adda di Fagagna, F. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm108 · Cited by 80
“SCC 15% (59) 27% (62)� 33% (60)� AC 23% (34) 33% (36)� 6% (32) LCC 0% (9) 33% (9)� 22% (9) Breast N/FC 0 (10) 91% ( 11 ) 0 (8)”
BackgroundResultInfluentialUpregulation of FOXM1 induces genomic instability in human epidermal keratinocytes
Teh, M., Gemenetzidis, E., Chaplin, T., Young, B. D., & Philpott, M. P. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-45 · Cited by 97
“The existence of DNA replication stress is a common feature in human pre-cancerous lesions [38] and recently, it has been shown that chronic induction of low, but not high, levels of Ras oncogene activation predisposes cells to tumour formation without inducing permanent cell cycle arrest [39].”
BackgroundChitikova, Z. V., Gordeev, S. A., Bykova, T. V., Zubova, S. G., Pospelov, V. A., & Pospelova, T. V. (2014) · Cell Cycle · doi:10.4161/cc.28402 · Cited by 77
“A large number of works demonstrate that establishment and maintenance of various types of cellular senescence are associated with the activation of DDR signaling and persistence of DDR foci.(1,11,15,28,54,55) The foci persistent in senescent cells may also reflect the chromatin rearrangement in the absence of DNA bre…”
BackgroundHgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers
Knauf, J. A., Luckett, K. A., Chen, K.-Y., Voza, F. A., Socci, N. D., Ghossein, R. A., & Fagin, J. A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120966 · Cited by 81
“In the absence of Trp53, BRAF-mutant cells can likely bypass the senescence or toxicity caused by the markedly increased MAPK flux (44, 45), which paradoxically could arise in part as a consequence of Trp53 loss.”
Caveolin-1, a master regulator of cellular senescence
Volonté, D., & Galbiati, F. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09875-w · Cited by 84
Cyclin E Deregulation Promotes Loss of Specific Genomic Regions
Teixeira, L. K., Wang, X., Li, Y., Ekholm‐Reed, S., Wu, X., Wang, P., & Reed, S. I. (2015) · Current Biology · doi:10.1016/j.cub.2015.03.022 · Cited by 83
Lazorthes, S., Vallot, C., Briois, S., Aguirrebengoa, M., Thuret, J.-Y., Laurent, G. S., Rougeulle, C., Kapranov, P., Mann, C., Trouche, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms6971 · Cited by 78
Corpet, A., Olbrich, T., Gwerder, M., Fink, D., & Stucki, M. (2014) · Cell Cycle · doi:10.4161/cc.26988 · Cited by 71
miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells
Neault, M., Mallette, F. A., & Richard, S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.068 · Cited by 85
PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress
Schleicher, E. M., Galvan, A. M., Kawasawa, Y. I., Moldovan, G., & Nicolae, C. M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky658 · Cited by 83
“as it activates the DNA damage and replication stress checkpoints leading to cell cycle arrest and/or senescence (21,22).”
BackgroundHornshøj, H., Nielsen, M. M., Sinnott-Armstrong, N. A., Świtnicki, M. P., Juul, M., Madsen, T., Sallari, R., Kellis, M., Ørntoft, T., Hobolth, A., et al. (2018) · npj Genomic Medicine · doi:10.1038/s41525-017-0040-5 · Cited by 74
“It mediates oncogenic activity through repression of the INK4/ARF tumor suppressor pathway(48) and is an activator of oncogenic senescence.(49) In breast cancer, its expression correlates with poor prognosis.”
BackgroundBreaking news: high-speed race ends in arrest – how oncogenes induce senescence
Micco, R. D., Fumagalli, M., & di Fagagna, F. D. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.07.012 · Cited by 94
Autophagy role(s) in response to oncogenes and DNA replication stress
Vanzo, R., Bartkova, J., Merchut-Maya, J. M., Hall, A., Bouchal, J., Dyrskjøt, L., Frankel, L. B., Gorgoulis, V., Maya-Mendoza, A., Jäättelä, M., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0403-9 · Cited by 79
“Deregulated oncogenes cause replication stress (RS) and DNA damage in cultured cells and mouse models [16], thereby triggering DNA damage response (DDR) checkpoints that provide a biological anti-cancer barrier in early stages of tumorigenesis, a concept shared by responses to diverse types of oncogenes, loss of some…”
BackgroundSelf-citationNakamura, M., Ohsawa, S., & Igaki, T. (2014) · Nature Communications · doi:10.1038/ncomms6264 · Cited by 79
Centrosome dysfunction: a link between senescence and tumor immunity
Wu, Q., Li, B., Liu, L., Sun, S., & Sun, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00214-7 · Cited by 81
Fan, G., Sun, L., Meng, L. H., Chen, H., Wang, X., Shi, Z., Hu, C., Han, Y., Yang, Q., Cao, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20208-x · Cited by 82
Aging of Liver in Its Different Diseases
Radonjić, T., Dukić, M., Jovanović, I., Zdravkovic, M. D., Mandić, O., Popadić, V., Popović, M., Nikolić, N., Klašnja, S., Divac, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113085 · Cited by 84
Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity
Köpper, F., Bierwirth, C., Schön, M., Kunze, M., Elvers, I., Kranz, D., Saini, P., Menon, M., Walter, D., Sørensen, C. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304355110 · Cited by 82
“However, replicative stress constitutes a limiting factor in cancer cell proliferation (1) and a major mechanism of chemotherapy, and thus merits detailed understanding.”
BackgroundSelf-citationUnexpected Pieces to the Senescence Puzzle
Cichowski, K. M., & Hahn, W. C. (2008) · Cell · doi:10.1016/j.cell.2008.05.027 · Cited by 86
“However, these observations do suggest that excessive CXCR signaling during oncogeneinduced senescence may allow for increased ROS accumulation, thus promoting the DNA-damage response and sustained activation of p53.”
Backgroundc-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress
Robinson, K., Asawachaicharn, N., Galloway, D. A., & Grandori, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005951 · Cited by 75
“Recent literature indicates that a hyper-replication phenotype leading to a DNA damage response and senescence is a common consequence to expression of activated ras and mos [36,37].”
BackgroundHow cells switch HIPK2 on and off
Sombroek, D., & Hofmann, T. G. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.154 · Cited by 87
Xu, M., Yu, Q., Subrahmanyam, R., Difilippantonio, M. J., Ried, T., & Sen, J. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01360-07 · Cited by 75
“DNA replication stress was also shown to result in prematurely terminated DNA replication forks and DNA doublestrand breaks and OIS in human diploid fibroblasts (1).”
BackgroundATM and ATR signaling at a glance
Awasthi, P., Foiani, M., & Kumar, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.188631 · Cited by 84
Mavrogonatou, E., Papadopoulou, A., Pratsinis, H., & Kletsas, D. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00178.2023 · Cited by 66
Self-citationZeng, L., Wu, G., Goh, K. J., Lee, Y. M., Ng, C. C., You, A. B., Wang, J., Jia, D., Hao, A., Yu, Q., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002329 · Cited by 78
“Furthermore, it was recently reported that in many cell types, the conversion from pre-cancer to cancer is accompanied by activation of the DNA damage response, which ceases to exist once converted to cancer cells [19,20].”
BackgroundRas-Induced Senescence and its Physiological Relevance in Cancer
DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 76
“Importantly, these studies also report that activation of the DNA damage response is required for oncogene-induced senescence, as supported by the lack of senescence upon genetic or chemical inactivation of CHK2, ATM or p53 [33,60].”
BackgroundResultThresholds of replication stress signaling in cancer development and treatment
Bártek, J., Mistrík, M., & Bártková, J. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2220 · Cited by 88
Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2
Xu, N., Hégarat, N., Black, E. J., Scott, M. T., Hochegger, H., & Gillespie, D. A. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201003004 · Cited by 87
Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?
Abbadie, C., Pluquet, O., & Pourtier, A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2587-9 · Cited by 83
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence
Haferkamp, S., Tran, S. L., Becker, T. M., Scurr, L. L., Kefford, R. F., & Rizos, H. (2009) · Aging · doi:10.18632/aging.100051 · Cited by 77
Mansour, W. Y., Bogdanova, N. V., Kasten-Pisula, U., Rieckmann, T., Köcher, S., Borgmann, K., Baumann, M. A., Krause, M., Petersen, C., Hu, H., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.10.020 · Cited by 78
“ATM-mediated DNA damage response (DDR) is a physiological barrier which is attenuated during carcinogenesis [29–33].”
BackgroundDynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability
Gaggioli, V., Lo, C. S. Y., Reverón-Gómez, N., Jasencakova, Z., Domènech, H., Nguyen, H. N., Sidoli, S., Tvardovskiy, A., Uruci, S., Slotman, J. A., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01167-z · Cited by 77
DNA damage response to the Mdm2 inhibitor Nutlin-3
Verma, R., Rigatti, M. J., Belinsky, G. S., Godman, C. A., & Giardina, C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.020 · Cited by 76
“Interestingly, some reports have indicated that the oncogene activation of p53 entails an induction of the DNA damage response [11,14,54].”
BackgroundDNA double-strand breaks: A potential causative factor for mammalian aging?
Li, H., Mitchell, J. R., & Hasty, P. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.002 · Cited by 83
Yang, C.-F., Peng, L.-X., Huang, T.-J., Yang, G.-D., Chu, Q.-Q., Liang, Y.-Y., Cao, X., Xie, P., Zheng, L.-S., Huang, H.-B., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.006 · Cited by 77
“ATM is important for the initiation of signaling in the DDR in mammalian cells [29].”
BackgroundDong, M., Wang, H.-Y., Zhao, X., Chen, J., Zhang, Y.-W., Huang, Y. J., Xue, L., Li, H., Du, H., Wu, X.-Y., et al. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.02.007 · Cited by 77
“A possible mechanism is that oncogene-induced senescence could provide a tumorigenesis barrier [24].”
BackgroundGenomic rearrangements induced by unscheduled DNA double strand breaks in somatic mammalian cells
So, A., Guen, T. L., López, B. S., & Guirouilh‐Barbat, J. (2017) · FEBS Journal · doi:10.1111/febs.14053 · Cited by 83
The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence
Tonnessen-Murray, C. A., Lozano, G., & Jackson, J. G. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026112 · Cited by 70
“Other oncogenic signals such as those from c-Mos and the Bcr-Abl fusion protein can induce senescence, although p53 dependence was not examined in these studies (Bartkova et al. 2006; Wajapeyee et al. 2010).”
BackgroundWillis, C. M., Nicaise, A. M., Bongarzone, E. R., Givogri, M., Reiter, C. R., Heintz, O., Jellison, E. R., Sutter, P. A., TeHennepe, G., Ananda, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57663-x · Cited by 76
STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation
Koganti, S. R. K., Hui‐Yuen, J. S., McAllister, S. C., Gardner, B., Grässer, F. A., Palendira, U., Tangye, S. G., Freeman, A. F., & Bhaduri‐McIntosh, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400683111 · Cited by 83
“Moreover, aberrant expression of oncogenes results in cell senescence or apoptosis, unless DDR is suppressed (3).”
BackgroundGuidi, R., Levi, L., Rouf, S. F., Puiac, S., Rhen, M., & Frisan, T. (2013) · Cellular Microbiology · doi:10.1111/cmi.12172 · Cited by 76
“…may contribute to the chronic activation of nonclassical oncogenes, such as NFκB and STAT3 (reviewed in Grivennikov et al., 2010), leading to the establishment of an inflammatory environment that could allow intoxicated cells to overcome the tumorigenesis barrier (Bartkova et al., 2006).”
BackgroundParallel pathways in RAF-induced senescence and conditions for its reversion
Jeanblanc, M., Ragu, S., Gey, C., Contrepois, K., Courbeyrette, R., Thuret, J., & Mann, C. (2011) · Oncogene · doi:10.1038/onc.2011.481 · Cited by 80
p53 Mediates Senescence-Like Arrest Induced by Chronic Replicational Stress
Marusyk, A., Wheeler, L. J., Mathews, C. K., & DeGregori, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01316-06 · Cited by 74
Wangsa, D., Quintanilla, I., Torabi, K., Vila-Casadesús, M., Ercilla, A., Klus, G. T., Yüce, Z., Galofré, C., Cuatrecasas, M., Lozano, J. J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700247rr · Cited by 80
Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype
Lau, L., & David, G. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1565658 · Cited by 70
“senescence (OIS), this form of cell cycle exit shares many features of replicative senescence, such as the activation of a DDR, resulting in this case from uncontrolled hyper-proliferation and subsequent fork collapse [17,18].”
BackgroundLindqvist, A., de Bruijn, M., Macurek, L., Brás, A., Mensinga, A., Bruinsma, W., Voets, O., Kranenburg, O., & Medema, R. H. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.246 · Cited by 75
Aziz, K., Limzerwala, J. F., Sturmlechner, I., Hurley, E., Zhang, C., Jeganathan, K. B., Nelson, G. G., Bronk, S. F., Velasco, R. O. F., van Deursen, E.-J., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.016 · Cited by 77
DNA replication and mitotic entry: A brake model for cell cycle progression
Lemmens, B. B. L. G., & Lindqvist, A. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201909032 · Cited by 78
“Examples of effectors of DNA damage checkpoints are ATM and the p53-p21 axis, which are critical for maintaining genome integrity but are not required for cell cycle progression per se (Bartkova et al., 2006; Sancar et al., 2004; Zhou and Elledge, 2000).”
BackgroundMisawa, T., Tanaka, Y., Okada, R., & Takahashi, A. (2020) · Geriatrics & Gerontology International · doi:10.1111/ggi.13928 · Cited by 69
Liu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
“Other onco-genes such as Mos, Cdc6, and Cyclin E have also been described as senescence inducers, reinforcing the notion that OIS provides a barrier to malignant progression [51].”
BackgroundOriganti, S., Cai, S.-R., Munir, A. Z., White, L. S., & Piwnica-Worms, H. (2013) · Oncogene · doi:10.1038/onc.2012.84 · Cited by 74
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Lin, H.-Y., Kao, C., Lin, K. M.-C., Kaartinen, V., & Yang, L.-T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015842 · Cited by 82
“Aberrant activation of bulge stem cells may create a replication stress that triggers DDR, and this notion is supported by several findings which correlate oncogene-induced aberrant DNA replication with DSB generation [48,49,50,51].”
BackgroundLiberal, V., Ahlzén, H.-S. M., Liberal, J., Spruck, C., Widschwendter, M., McGowan, C. H., & Reed, S. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102434108 · Cited by 83
“Cyclin E is an oncoprotein implicated in breast cancer etiology that has been shown to trigger the DNA damage response (28).”
BackgroundSelenium Compounds Activate Early Barriers of Tumorigenesis
Wu, M., Kang, M. M., Schoene, N. W., & Cheng, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088781 · Cited by 80
Connecting the Dots: From DNA Damage and Repair to Aging
Pan, M., Li, K., Lin, S., & Hung, W.-C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050685 · Cited by 80
“Previous studies showed that oncogene-induced senescence in fibroblasts is a DDR triggered by replication dysregulation, because of the elevated replication stress from unregulated proliferation [58,59].”
BackgroundATM regulation of IL-8 links oxidative stress to cancer cell migration and invasion
Chen, W.-T., Ebelt, N. D., Stracker, T. H., Xhemalce, B., Van Den Berg, C. L., & Miller, K. M. (2015) · eLife · doi:10.7554/elife.07270 · Cited by 73
“…anti-cancer barriers to limit proliferation in response to, and in the presence of, DNA damage (Norbury and Zhivotovsky, 2004; Bartkova et al., 2005; Gorgoulis et al., 2005; Bartkova et al., 2006; Di Micco et al., 2006; Vousden and Lane, 2007; Sherman et al., 2011; Roos and Kaina, 2013).”
BackgroundEmerging Roles of SRSF3 as a Therapeutic Target for Cancer
Zhou, Z., Gong, Q., Lin, Z., Wang, Y., Li, M., Wang, L., Ding, H., & Li, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.577636 · Cited by 79
PIG3: A novel link between oxidative stress and DNA damage response in cancer
Kotsinas, A., Aggarwal, V., Tan, E.-J., Levy, B., & Gorgoulis, V. G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.009 · Cited by 65
Self-citationCdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways
Gao, D., Inuzuka, H., Korenjak, M., Tseng, A., Wu, T., Wan, L., Kirschner, M. W., Dyson, N. J., & Wei, W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0092 · Cited by 81
“…various stresses, including DNA damage (Robles and Adami, 1998), oxidative stress (Chen et al., 1998), and expression of active oncogenic proteins (Bartkova et al., 2006; Koutsami et al., 2006; Mallette et al., 2007) has been proposed as a built-in fail-safe mechanism against cancer development…”
Liakou, E., Mavrogonatou, E., Pratsinis, H., Rizou, S., Evangelou, K., Panagiotou, P. N., Karamanos, N. K., Gorgoulis, V. G., & Kletsas, D. (2016) · Aging · doi:10.18632/aging.100989 · Cited by 72
Self-citationLoss of lamin B receptor is necessary to induce cellular senescence
Lukášová, E., Kovarˇík, A., Bacˇíková, A., Falk, M., & Kozubek, S. (2017) · Biochemical Journal · doi:10.1042/bcj20160459 · Cited by 69
Endothelial Senescence: A New Age in Pulmonary Hypertension
Culley, M. K., & Chan, S. Y. (2022) · Circulation Research · doi:10.1161/circresaha.121.319815 · Cited by 75
Frank, A. O., Feldkamp, M. D., Kennedy, J. P., Waterson, A. G., Pelz, N. F., Patrone, J. D., Vangamudi, B., Camper, D. V., Rossanese, O. W., Chazin, W. J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401333u · Cited by 67
“5-(4-((4-(5-Carboxyfuran-2-yl)benzyl)oxy)phenyl)-1-(m-tolyl)-1H-pyrazole-3-carboxylic acid (7)”
Cdk2: a key regulator of the senescence control function of Myc
Hydbring, P., & Larsson, L. (2010) · Aging · doi:10.18632/aging.100140 · Cited by 81
“Depending on the type of lesion, DDR can cause activation of p53 via pathways involving the checkpoint kinases ATM and Chk2 or ATR and Chk1, which in turn induces p53 [19,20].”
BackgroundDietlein, F., Thelen, L., Jokić, M., Jachimowicz, R. D., Ivan, L., Knittel, G., Leeser, U., van Oers, J., Edelmann, W., Heukamp, L. C., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0907 · Cited by 73
Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile
Jing, F., Hu, X., Cao, Y., Xu, M., Wang, Y., Jing, Y., Hu, X., Gao, Y., & Zhu, Z. (2018) · IUBMB Life · doi:10.1002/iub.1748 · Cited by 76
Translational control and the cancer cell response to stress
Robichaud, N., & Sonenberg, N. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.05.007 · Cited by 70
PARP mediated DNA damage response, genomic stability and immune responses
Zong, C., Zhu, T., He, J., Huang, R., Jia, R., & Shen, J. (2022) · International Journal of Cancer · doi:10.1002/ijc.33918 · Cited by 74
Cisplatin-induced senescence in ovarian cancer cells is mediated by GRP78
Li, W., Wang, W., Dong, H., Li, Y., Li, L., Han, L., Han, Z., Wang, S., Ma, D., & Wang, H. (2014) · Oncology Reports · doi:10.3892/or.2014.3147 · Cited by 73
Nikolaev, S. I., Sotiriou, S. K., Pateras, I. S., Santoni, F., Sougioultzis, S., Edgren, H., Almusa, H., Robyr, D., Guipponi, M., Saarela, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3869 · Cited by 70
Self-citationThe versatile functions of ATM kinase
Xu, B., & Boohaker, R. J. (2014) · Biomedical Journal · doi:10.4103/2319-4170.125655 · Cited by 77
Aylon, Y., Yabuta, N., Besserglick, H., Buganim, Y., Rotter, V., Nojima, H., & Oren, M. (2009) · Oncogene · doi:10.1038/onc.2009.270 · Cited by 83
Nucleotide Pool Depletion Induces G-Quadruplex-Dependent Perturbation of Gene Expression
Papadopoulou, C., Guilbaud, G., Schiavone, D., & Sale, J. E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.039 · Cited by 71
Tyagi, S., & Herr, W. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.258 · Cited by 77
“The function of E2F1 in the oncogene-induced DDR leading to senescence is not well understood (Bartkova et al, 2006; Di Micco et al, 2006).”
BackgroundLee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 71
“Oncogenic activation-induced senescence has commonly been observed in premalignant tumors; however, it is rare in the malignant counterparts [164, 171, 172, 185, 190, 191].”
BackgroundThe p38 and Hog1 SAPKs control cell cycle progression in response to environmental stresses
Duch, A., de Nadal, E., & Posas, F. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.034 · Cited by 67
The thyroid hormone receptor β induces DNA damage and premature senescence
Zambrano, A., García-Carpizo, V., Gallardo, M. E., Villamuera, R., Gómez-Ferrería, M. A., Pascual, A., Buisine, N., Sachs, L. M., Garesse, R., & Aranda, A. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201305084 · Cited by 68
“…(DDR) secondary to oxidative stress that induces double-strand breaks (DSBs; Campisi and d'Adda di Fagagna, 2007) or to DNA replication stress induced by oncogenes or drugs, which lead to DSB generation and DDR activation (Serrano et al., 1997; Bartkova et al., 2006; Di Micco et al., 2006).”
The secret life of Bcl-2: Apoptosis-independent inhibition of DNA repair by Bcl-2 family members
Laulier, C., & López, B. S. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.05.002 · Cited by 80
“DNA breaks and the activation of a DNA damage response (DDR) have been observed in non-treated, precancerous cells and have been interpreted to be the result of spontaneous replicative stress [69,70].”
BackgroundNanomedicine: Photo-activated nanostructured titanium dioxide, as a promising anticancer agent
Lаgopati, N., Evangelou, K., Falaras, P., Tsilibary, E.-P. C., Vasileiou, P. V. S., Havaki, S., Angelopoulou, A., Pavlatou, E. A., & Gorgoulis, V. G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107795 · Cited by 71
Self-citationCdc6 as a novel target in cancer: Oncogenic potential, senescence and subcellular localisation
Lim, N., & Townsend, P. A. (2020) · International Journal of Cancer · doi:10.1002/ijc.32900 · Cited by 73
“Essentially, an oncogene-induced DNA damage occurs— triggering replicative stress in the form of DNA DSB—leading to a DDR, the bypass of which is critical in tumour progression.(13,19,20,22) There are a few key points to be made about senescence and its association in cancers; senescence markers have been found in pre…”
BackgroundInfluentialGao, Y., Liu, Y., Liu, Y., Peng, Y., Yuan, B., Fu, Y., Qi, X., Zhu, Q., Cao, T., Zhang, S., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.012 · Cited by 69
ATR promotes clearance of damaged DNA and damaged cells by rupturing micronuclei
Joo, Y. K., Black, E. M., Trier, I., Haakma, W. E., Zou, L., & Kabeche, L. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.09.003 · Cited by 72
Defining the toxicology of aging
Sorrentino, J. A., Sanoff, H. K., & Sharpless, N. E. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.04.004 · Cited by 75
“…anu sc r i p t promote molecular aging, causing chronic changes in exposed tissues in the expression of multiple senescence biomarkers including expression of SASP factors [91, 92], LTL shortening [24, 93], and induction of p16 INK4a and other senescence-associated tumor suppressor genes [34, 94].”
BackgroundInterplay between ATM and ATR in the regulation of common fragile site stability
Ozeri-Galai, E., Schwartz, M., Rahat, A., & Kerem, B. (2007) · Oncogene · doi:10.1038/sj.onc.1210849 · Cited by 78
“In addition, overexpression of oncogenes, was shown to result in replication stress and replication-dependent DSBs formation (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundDDB1-CUL4 and MLL1 Mediate Oncogene-Induced p16 INK4a Activation
Kotake, Y., Zeng, Y., & Xiong, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2739 · Cited by 69
Burton, D. G. A., Giribaldi, M. G., Muñoz, A., Halvorsen, K. T., Patel, A., Jordà, M., Perez‐Stable, C., & Rai, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068003 · Cited by 73
“subpopulations [25–27].”
Caveolin‐1 deficiency induces premature senescence with mitochondrial dysfunction
Yu, D., Jung, S. H., An, H., Lee, S., Hong, J., Park, J. S., Lee, H., Lee, H., Bahn, M., Lee, H. C., et al. (2017) · Aging Cell · doi:10.1111/acel.12606 · Cited by 66
“Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. senescence (Bartkova et al., 2006; Mallette et al., 2007), while their inactivation also leads to senescence (Ju et al., 2006).”
BackgroundAutophagy maintains stem cells and intestinal homeostasis in Drosophila
Nagy, P., Sándor, G. O., & Juhász, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-23065-3 · Cited by 72
Kanellis, P., Gagliardi, M., Banáth, J. P., Szilard, R. K., Nakada, S., Galicia, S., Sweeney, F. D., Cabelof, D. C., Olive, P. L., & Durocher, D. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030134 · Cited by 70
“appears to be a hallmark of precancerous and hyperproliferating cells [57,58].”
BackgroundKilic Eren, M., Kilincli, A., & Eren, Ö. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124837 · Cited by 68
Replication Stress Defines Distinct Molecular Subtypes Across Cancers
Takahashi, N., Kim, S. H., Schultz, C. W., Rajapakse, V. N., Zhang, Y., Redon, C. E., Fu, H., Pongor, L. S., Kumar, S., Pommier, Y. G., et al. (2021) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0168 · Cited by 70
Metadata
- Authors
- Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C. L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bartek, J., & Gorgoulis, V. G.
- Affiliations
- The Wistar Institute (US)
- National and Kapodistrian University of Athens (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Stockholm University (SE)
- University of Ioannina (GR)
- National Hellenic Research Foundation (GR)
- University of Pennsylvania (US)
- Danish Cancer Society (DK)
- Copenhagen University Hospital (DK)
- Aarhus University Hospital (DK)
- Corresponding author
- Halazonetis, Thanos D.
- ORCID
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 633-637
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2041156660
- Cited by
- 1,986
- References
- 30
- Citations by year
- 2026: 35 · 2025: 74 · 2024: 65 · 2023: 92 · 2022: 74 · 2021: 96 · 2020: 88 · 2019: 83 · 2018: 108 · 2017: 100 · 2016: 122 · 2015: 88 · 2014: 134 · 2013: 129 · 2012: 132
- FWCI
- 65.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, DNA damage response, replication stress, DNA double-strand breaks, ATM kinase, precancerous lesions, senescence markers, tumor progression, apoptosis
- MeSH terms
- Animals, Cell Line, Cell Transformation, Neoplastic, DNA, DNA Damage, DNA Replication, Humans, Neoplasm Invasiveness, Nuclear Proteins, Oncogenes, Precancerous Conditions, Genes, mos, Cellular Senescence, Cell Cycle Proteins, Cyclin E, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.